NanoCellect Biomedical Adds to Executive Leadership Team with New VP of Finance
SAN DIEGO, Calif., September 25, 2019 — NanoCellect Biomedical, Inc., a leader in the development and manufacturing of modern and simple solutions for cell-based assays, today announced that Jeremy Baker has joined the company as its new Vice President of Finance. In this role, he will oversee the company’s finance and accounting team and help guide the company’s broader strategic planning and growth.
“Jeremy brings a wealth of experience to the NanoCellect team, and we’re delighted that he has joined the company,” said Chris Neary, CEO of NanoCellect Biomedical. “As we continue to grow and expand this company’s global footprint, Jeremy will play a significant role, across all of our departments, to ensure we meet our financial objectives and continue to provide value to both our customers and our investors.”
Jeremy has over 20 years of finance, accounting, treasury and operations experience in the telecommunications, software, and biotechnology industries. Most recently, he served as Director of Finance for San Diego-based antibodies and reagents manufacturer BioLegend, where he built out the finance and accounting infrastructure and helped scale the company for future growth. Prior to BioLegend, he was the Director of Finance for Inseego Corporation. Baker holds a BS from the University of Richmond and an MBA from the University of California, Los Angeles (UCLA).
This is the second addition to NanoCellect’s executive leadership team this quarter. In July, Dr. Paul DiGregorio joined the company as its new Vice President of Commercial.
To learn more about NanoCellect and its products, please visit https://www.nanocellect.com.
About NanoCellect Biomedical, Inc.
NanoCellect is a life science tools company that develops and manufactures innovative solutions for cell analysis and sorting based on gentle, sterile, microfluidic technology. NanoCellect’s WOLF® Cell Sorter and N1 single-cell plate dispenser allow researchers to perform antibody discovery, cell line development, genomic sample preparation and CRISPR genome editing faster, without contamination. The compact, sturdy and affordable system allows researchers to safely perform cell sorting and single-cell plating experiments at their convenience. Founded in 2009, NanoCellect is headquartered in San Diego. Learn more at www.nanocellect.com.